Simon N. Pimstone - Net Worth and Insider Trading
Simon N. Pimstone Net Worth
The estimated net worth of Simon N. Pimstone is at least $255,780 dollars as of 2024-12-01. Simon N. Pimstone is the Director of Xenon Pharmaceuticals Inc and owns about 6,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $255,780. Details can be seen in Simon N. Pimstone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Simon N. Pimstone has not made any transactions after 2023-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Simon N. Pimstone
Simon N. Pimstone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Simon N. Pimstone owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Simon N. Pimstone’s form 4 insider trades.
Insider Ownership Summary of Simon N. Pimstone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-06-01 | director |
Simon N. Pimstone Latest Holdings Summary
Simon N. Pimstone currently owns a total of 1 stock. Simon N. Pimstone owns 6,000 shares of Xenon Pharmaceuticals Inc (XENE) as of June 1, 2023, with a value of $255,780.
Latest Holdings of Simon N. Pimstone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-06-01 | 6,000 | 42.63 | 255,780 |
Holding Weightings of Simon N. Pimstone
Simon N. Pimstone Form 4 Trading Tracker
According to the SEC Form 4 filings, Simon N. Pimstone has made a total of 7 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 131,245 shares on June 1, 2023, which brought Simon N. Pimstone around $5 Million.
Insider Trading History of Simon N. Pimstone
- 1
Simon N. Pimstone Trading Performance
GuruFocus tracks the stock performance after each of Simon N. Pimstone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Simon N. Pimstone is -10.91%. GuruFocus also compares Simon N. Pimstone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Simon N. Pimstone within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Simon N. Pimstone's insider trading performs compared to the benchmark.
Performance of Simon N. Pimstone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.91 | | | | | |
| Relative Return to S&P 500(%) | 9.96 | | | | | |
Simon N. Pimstone Ownership Network
Simon N. Pimstone Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Simon N. Pimstone is the director of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Simon N. Pimstone made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 31,467 shares made by Gary Patou , a net sale of 25,000 shares made by Dawn Svoronos , and a net sale of 13,000 shares made by Steven Gannon .
In summary, during the past 3 months, insiders sold 4,891 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 4,891 shares. During the past 18 months, 78,696 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,696 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Simon N. Pimstone Mailing Address
Above is the net worth, insider trading, and ownership report for Simon N. Pimstone. You might contact Simon N. Pimstone via mailing address: 200 - 3650 Gilmore Way, Burnaby A1 V5g4w8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
